Big Tree Cloud Holdings Limited revenue by segment DSYWW
Big Tree Cloud Holdings Limited splits its revenue into 10 lines in its filings. The largest line in fiscal 2026, which ended Jun 30, 2026 was Body And Oral Care Products at $493,238, 76% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Jun 30, 2025
|
FY 2024
Jun 30, 2024
|
|---|---|---|---|
| Revenue |
1
|
1
|
7
|
| Offline |
—
|
1
-59.4%
share 97.1%
|
3
share 41.5%
|
| Accessories |
—
|
—
|
1
share 13.9%
|
| Body And Oral Care Products |
0
+61.1%
share 76.5%
|
0
-70.8%
share 24.1%
|
1
share 14.3%
|
| AI Technology Services |
0
share 18.3%
|
—
|
—
|
| License |
—
|
—
|
0
share 0.6%
|
| Product Sales Other |
0
share 4.7%
|
—
|
—
|
| Online |
—
|
0
-99.4%
share 2.1%
|
4
share 57.9%
|
| Licensing Fees One |
—
|
0
-75.5%
share 0.8%
|
0
share 0.6%
|
| Sanitary Pads |
0
-99.6%
share 0.6%
|
1
-81.5%
share 75.1%
|
5
share 70.5%
|
| Others |
—
|
0
-100.0%
share 0.0%
|
0
share 0.8%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.
Company profile
- Industry
- Converted Paper & Paperboard Prods (No Contaners/Boxes) (SIC 2670)
- Listed as
- DSY (Nasdaq), DSYWW (Nasdaq)
- Fiscal year ends
- June 30
- Incorporated in
- Cayman Islands
- Headquarters
- Shenzhen, China
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1999297
Other Converted Paper & Paperboard Prods (No Contaners/Boxes) companies
- Kimberly Clark Corp KMB
- Avery Dennison Corp AVY
- Ranpak Holdings Corp. PACK
- It Tech Packaging, Inc. ITP
All 5 Converted Paper & Paperboard Prods (No Contaners/Boxes) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.